Cargando…

Challenges in modulating insulin receptor signalling as a therapeutic strategy for cancer

Detalles Bibliográficos
Autores principales:	Srinivas, Priya, Pillai, Madhavan Radhakrishna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118136/ https://www.ncbi.nlm.nih.gov/pubmed/30168483 http://dx.doi.org/10.4103/ijmr.IJMR_732_18

Ejemplares similares

Therapeutic application of nitric oxide in cancer & inflammatory disorders
por: Srinivas, Priya, et al.
Publicado: (2020)

Polymorphism of p53 in cancer prognosis
por: Pillai, Radhakrishna Madhavan, et al.
Publicado: (2016)

Fractalkine signaling in regulation of insulin secretion: Mechanisms and potential therapeutic implications?
por: Gregg, Brigid, et al.
Publicado: (2014)

B cell receptor signaling strength modulates cancer immunity
por: Ye, Jian, et al.
Publicado: (2022)

Selective Insulin Receptor Modulators (SIRM): A New Class of Antidiabetes Drugs?
por: Vigneri, Riccardo, et al.
Publicado: (2012)

Smurf2 E3 ubiquitin ligase modulates proliferation and invasiveness of breast cancer cells in a CNKSR2 dependent manner
por: David, Diana, et al.
Publicado: (2014)

Insulin receptor trafficking steers insulin action
por: Hausmann, Simone, et al.
Publicado: (2016)

Prognostic Significance of Dysregulated Epigenomic and Chromatin Modifiers in Cervical Cancer
por: Paul, Aswathy Mary, et al.
Publicado: (2021)

Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells
por: Parvathy, Muraleedharan, et al.
Publicado: (2016)

Challenges and Opportunities in Pharmacogenomics and Therapeutics
por: Kane, Michael D., et al.
Publicado: (2007)

Brain insulin receptors link stress and metabolism()
por: Woods, Stephen C., et al.
Publicado: (2014)

Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics
por: George, Bijesh, et al.
Publicado: (2021)

Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington’s Disease
por: Simmons, Danielle A.
Publicado: (2017)

Insulin resistance in the brain: A new therapeutic target for Alzheimer's disease
por: Umegaki, Hiroyuki
Publicado: (2013)

Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics
por: Wei, Wen-Chi, et al.
Publicado: (2022)

Life history theory and breast cancer risk: methodological and theoretical challenges: Response to “Is estrogen receptor negative breast cancer risk associated with a fast life history strategy?”
por: Aktipis, Athena
Publicado: (2016)

Challenges and patenting strategies for Chinese herbal medicine
por: Wang, Xinsheng, et al.
Publicado: (2010)

Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?
por: Heinecke, Jay W., et al.
Publicado: (2014)

Inceptor intercepts insulin signaling in pancreatic β‐cells
por: Watada, Hirotaka
Publicado: (2021)

Using Oral Challenge Testing to Assess Insulin Action and Secretion With Mathematical Modeling
por: Staten, Myrlene A., et al.
Publicado: (2014)

Tight glucose control: should we move from intensive insulin therapy alone to modulation of insulin and nutritional inputs?
por: Kalfon, Pierre, et al.
Publicado: (2008)

Glucocorticoid Receptor Antagonism as a New “Remedy” for Insulin Resistance—Not There Yet!
por: Varlamov, Elena V, et al.
Publicado: (2021)

Endothelial Insulin and IGF-1 Receptors: When Yes Means NO
por: Muniyappa, Ranganath, et al.
Publicado: (2012)

Lung Cancer and Human Papilloma Viruses (HPVs): Examining the Molecular Evidence
por: Prabhu, Priya R., et al.
Publicado: (2012)

Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment?
por: Ruiz de Porras, Vicenç
Publicado: (2022)

Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
por: Fu, Dongliao, et al.
Publicado: (2022)

Prevention of breast cancer using selective oestrogen receptor modulators (SERMs)
por: Powles, Trevor J
Publicado: (2006)

Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021)

Challenges and strategies to research ethics in conducting COVID‐19 research
por: Ma, Xitao, et al.
Publicado: (2020)

A challenge to claims for mycorrhizal-transmitted wound signaling
por: Blatt, Michael R., et al.
Publicado: (2023)

Approaching the challenges of MKK3/p38delta MAPK targeting for therapeutic purpose in colorectal cancer
por: Stramucci, Lorenzo, et al.
Publicado: (2019)

Endothelium-Derived Hyperpolarizing Factors: A Potential Therapeutic Target for Vascular Dysfunction in Obesity and Insulin Resistance
por: Jia, Guanghong, et al.
Publicado: (2016)

Modulating gut microbial metabolism in heart failure: Opportunities and challenges
por: Tang, W. H. Wilson, et al.
Publicado: (2021)

Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
por: Tigyi, Gábor, et al.
Publicado: (2021)

Towards a regional strategy for resolving the human resources for health challenges in Africa
por: Asamani, James Avoka, et al.
Publicado: (2019)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013)

Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
por: Holmes, Emily A. F., et al.
Publicado: (2019)

Metastasis-associated protein 1 is an upstream regulator of DNMT3a and stimulator of insulin-growth factor binding protein-3 in breast cancer
por: Deivendran, S., et al.
Publicado: (2017)

Acute Modulation of Toll-Like Receptors by Insulin
por: Ghanim, Husam, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_2dmk8ku8advu5t8f1a65u455r0